Grifols | GRFS - Umlaufvermögen

Aktienkurs
8.08
Täglich Wechseln
0.09 1.13%
Monatlich
4.80%
Jährlich
12.07%
Q2 Prognose
7.87




Umlaufvermögen Veränderung Datum
Alaunos Therapeutics USD 2.68M 1.05M 2025-09
Arca Biopharma USD 343.86M 11.31M 2025-12
aTyr Pharma USD 245.8M 152.79M 2025-12
Bio Path USD 663K 17K 2025-09
Brainstorm Cell Therapeutics USD 307K 201K 2025-12
Capricor Therapeutics USD 322.94M 221.99M 2025-12
Cara Therapeutics USD 38.44M 4.69M 2025-09
Esperion Therapeutics USD 462.57M 102.11M 2025-12
GlaxoSmithKline GBP 17.51B 332M 2025-12
Grifols EUR 5.96B 316.31M 2025-12
Immunic USD 39.27M 20.57M 2025-09
Infinity Pharmaceuticals USD 19.91M 8.46M 2023-06
Minerva Neurosciences USD 83.1M 70.08M 2025-12
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Sangamo BioSciences USD 49.89M 12.3M 2025-06
TherapeuticsMD USD 11.82M 303K 2024-06